Pharma Journalist -

Cytovia Therapeutics (“Cytovia”), an emerging biopharmaceutical company developing Natural Killer (NK) immunotherapies for cancer and infectious diseases, announced that it is expanding…
Read More...

HitGen Inc. (HitGen) announced that HitGen and Mitsubishi Tanabe Pharma Corporation (MTPC) have entered into a license agreement to develop a novel class of drugs. This is the second…
Read More...

Gilead Sciences, Inc. announced the completion of the previously announced transaction for Toro Merger Sub, Inc., a wholly owned subsidiary of Gilead (“Purchaser”), to acquire Forty…
Read More...

Gilead Sciences, Inc. and Second Genome announced that the companies have entered into a four-year strategic collaboration to identify biomarkers associated with clinical response in up…
Read More...

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Philadelphia 2020 into a completely virtual event. To safeguard the…
Read More...

CROMSOURCE, an international contract research organization (CRO) with its global headquarters in Verona, Italy, has announced that it has initiated its first COVID-19 trial on behalf…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the New Drug Application (NDA) of…
Read More...

SMi Reports: Associates of Cape Cod to host an online webinar taking place on Wednesday 29th April 2020. SMi Group is delighted to announce a free webinar led by Associates of Cape…
Read More...

SMi Reports: Novartis presentation details released for the Injectable Drug Delivery conference, this September The highly anticipated 3rd annual Injectable Drug Delivery conference,…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses,…
Read More...